Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CVAC CureVac > Detailed Quotes

CVAC CureVac

7.480
-0.070-0.93%
Close 09/23 16:00 ET
7.470
-0.010-0.13%
Post Mkt Price 09/23 16:00 ET
High
7.590
Open
7.360
Turnover
6.30M
Low
6.990
Pre Close
7.550
Volume
879.97K
Market Cap
1.40B
P/E(TTM)
Loss
52wk High
58.360
Shares
187.47M
P/E(Static)
Loss
52wk Low
6.990
Float Cap
634.70M
Bid/Ask %
0.00%
Historical High
151.800
Shs Float
84.85M
Volume Ratio
2.18
Historical Low
6.990
Dividend TTM
--
Div Yield TTM
--
P/B
2.26
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.04%
Amplitude
7.95%
Avg Price
7.157
Lot Size
1
Float Cap
634.70M
Bid/Ask %
0.00%
Historical High
151.800
Shs Float
84.85M
Volume Ratio
2.18
Historical Low
6.990
Dividend TTM
--
P/B
2.26
Dividend LFY
--
Turnover Ratio
1.04%
Amplitude
7.95%
Avg Price
7.157
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
CEO: Mr. Franz-Werner Haas, L.L.D.,L.L.M.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...